Concepedia

Colin Rothwell

CR

Statistics

Publications

5

Citations

476

H-Index

5

Active since

2018

Affiliations

Cornell University(Current)

Duke University

Duke Medical Center

Epic Sciences (United States)

Johns Hopkins University

Colin Rothwell is an author at Cornell University specializing in oncology, medicine, and circulating tumor cell characterization.

Publications per year

2018–2019

5

Publications

5

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

Andrew J. Armstrong, Susan Halabi, Jun Luo et al. · Journal of Clinical Oncology · 2019 · 364 citations · Full text

Medicine, Oncology, Pharmacology +17

Thunderclap: Exploring Vulnerabilities in Operating System IOMMU Protection via DMA from Untrustworthy Peripherals

A. Theodore Markettos, Colin Rothwell, Brett F. Gutstein et al. · 2019 · 53 citations · Full text

Computing, Computer Science, Computer Systems +17

Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer

Santosh Gupta, Daniel H. Hovelson, Gabor Kemeny et al. · Genes Chromosomes and Cancer · 2019 · 30 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer

Andrew J. Armstrong, Santosh Gupta, Patrick Healy et al. · PLoS ONE · 2019 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

The PROPHECY trial: Multicenter prospective trial of circulating tumor cell (CTC) AR-V7 detection in men with mCRPC receiving abiraterone (A) or enzalutamide (E).

Andrew J. Armstrong, Susan Halabi, Jun Luo et al. · Journal of Clinical Oncology · 2018 · 12 citations

Medicine, Oncology, Pharmacotherapy +17

1–5 of 5